Published in Heart Fail Rev on September 01, 2015
Deregulated Ca(2+) cycling underlies the development of arrhythmia and heart disease due to mutant obscurin. Sci Adv (2017) 0.75
The Role of Genetic Testing in the Identification of Young Athletes with Inherited Primitive Cardiac Disorders at Risk of Exercise Sudden Death. Front Cardiovasc Med (2016) 0.75
Bringing It All Together: Bedside to Bench and Back Again. Circ Res (2015) 0.75
Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J (2007) 6.34
Truncations of titin causing dilated cardiomyopathy. N Engl J Med (2012) 6.07
A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation. Cell (1990) 5.77
The complete gene sequence of titin, expression of an unusual approximately 700-kDa titin isoform, and its interaction with obscurin identify a novel Z-line to I-band linking system. Circ Res (2001) 3.68
Titin isoform switch in ischemic human heart disease. Circulation (2002) 3.05
Protein kinase G modulates human myocardial passive stiffness by phosphorylation of the titin springs. Circ Res (2008) 2.73
Mutations of TTN, encoding the giant muscle filament titin, cause familial dilated cardiomyopathy. Nat Genet (2002) 2.67
Developmental control of titin isoform expression and passive stiffness in fetal and neonatal myocardium. Circ Res (2004) 2.38
Genetic basis of hypertrophic cardiomyopathy: from bench to the clinics. J Cardiovasc Electrophysiol (2007) 2.18
Calcium-dependent molecular spring elements in the giant protein titin. Proc Natl Acad Sci U S A (2003) 2.16
Low myocardial protein kinase G activity in heart failure with preserved ejection fraction. Circulation (2012) 2.14
Protein kinase A phosphorylates titin's cardiac-specific N2B domain and reduces passive tension in rat cardiac myocytes. Circ Res (2002) 2.07
Identification of a novel frameshift mutation in the giant muscle filament titin in a large Australian family with dilated cardiomyopathy. J Mol Med (Berl) (2006) 2.05
Cardiomyopathy in zebrafish due to mutation in an alternatively spliced exon of titin. Nat Genet (2002) 1.99
Muscle giants: molecular scaffolds in sarcomerogenesis. Physiol Rev (2009) 1.92
PKC phosphorylation of titin's PEVK element: a novel and conserved pathway for modulating myocardial stiffness. Circ Res (2009) 1.91
Cardiac titin: a multifunctional giant. Circulation (2010) 1.84
The NH2 terminus of titin spans the Z-disc: its interaction with a novel 19-kD ligand (T-cap) is required for sarcomeric integrity. J Cell Biol (1998) 1.78
Abnormal contractile properties of muscle fibers expressing beta-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy. J Clin Invest (1995) 1.75
Titin mutations as the molecular basis for dilated cardiomyopathy. Biochem Biophys Res Commun (2002) 1.70
Hypertrophic cardiomyopathy:a paradigm for myocardial energy depletion. Trends Genet (2003) 1.62
Titin-actin interaction in mouse myocardium: passive tension modulation and its regulation by calcium/S100A1. Biophys J (2001) 1.59
Genetic variation in titin in arrhythmogenic right ventricular cardiomyopathy-overlap syndromes. Circulation (2011) 1.51
The structure of the sarcomeric M band: localization of defined domains of myomesin, M-protein, and the 250-kD carboxy-terminal region of titin by immunoelectron microscopy. J Cell Biol (1996) 1.49
Structural analysis of the titin gene in hypertrophic cardiomyopathy: identification of a novel disease gene. Biochem Biophys Res Commun (1999) 1.48
C-terminal titin deletions cause a novel early-onset myopathy with fatal cardiomyopathy. Ann Neurol (2007) 1.47
Conditional expression of mutant M-line titins results in cardiomyopathy with altered sarcomere structure. J Biol Chem (2002) 1.47
Gigantic variety: expression patterns of titin isoforms in striated muscles and consequences for myofibrillar passive stiffness. J Muscle Res Cell Motil (2003) 1.40
Cardiac ankyrin repeat protein gene (ANKRD1) mutations in hypertrophic cardiomyopathy. J Am Coll Cardiol (2009) 1.38
M line-deficient titin causes cardiac lethality through impaired maturation of the sarcomere. J Cell Biol (2006) 1.29
Crucial role for Ca2(+)/calmodulin-dependent protein kinase-II in regulating diastolic stress of normal and failing hearts via titin phosphorylation. Circ Res (2013) 1.20
Targeted homozygous deletion of M-band titin in cardiomyocytes prevents sarcomere formation. J Cell Sci (2006) 1.18
Expression profiling of cardiac genes in human hypertrophic cardiomyopathy: insight into the pathogenesis of phenotypes. J Am Coll Cardiol (2001) 1.17
Functional analysis of titin/connectin N2-B mutations found in cardiomyopathy. J Muscle Res Cell Motil (2005) 1.16
Modulation of titin-based stiffness by disulfide bonding in the cardiac titin N2-B unique sequence. Biophys J (2009) 1.15
A novel mechanism involving four-and-a-half LIM domain protein-1 and extracellular signal-regulated kinase-2 regulates titin phosphorylation and mechanics. J Biol Chem (2012) 1.12
S-glutathionylation of cryptic cysteines enhances titin elasticity by blocking protein folding. Cell (2014) 1.09
The sarcomere and sarcomerogenesis. Adv Exp Med Biol (2008) 1.08
Recessive TTN truncating mutations define novel forms of core myopathy with heart disease. Hum Mol Genet (2013) 1.01
Doubly heterozygous LMNA and TTN mutations revealed by exome sequencing in a severe form of dilated cardiomyopathy. Eur J Hum Genet (2013) 1.00
Titin mutation in familial restrictive cardiomyopathy. Int J Cardiol (2013) 0.97
Enhanced nitrosative stress during Trypanosoma cruzi infection causes nitrotyrosine modification of host proteins: implications in Chagas' disease. Am J Pathol (2008) 0.97
Fishing out proteins that bind to titin. J Cell Biol (2001) 0.92
Myocardial titin and collagen in cardiac diastolic dysfunction: partners in crime. Circulation (2013) 0.87
Stressing the giant: a new approach to understanding dilated cardiomyopathy. J Mol Cell Cardiol (2009) 0.84
A novel titin mutation in adult-onset familial dilated cardiomyopathy. Am J Cardiol (2012) 0.80
Molecular etiology of idiopathic cardiomyopathy in Asian populations. J Cardiol (2001) 0.77
Molecular etiology of idiopathic cardiomyopathy. Acta Myol (2007) 0.77
Titin and the developing heart. Circ Res (2004) 0.75
Attenuation of toll-like receptor 2-mediated innate immune response in patients with alcoholic chronic liver disease. Liver Int (2010) 2.20
Low myocardial protein kinase G activity in heart failure with preserved ejection fraction. Circulation (2012) 2.14
Hypophosphorylation of the Stiff N2B titin isoform raises cardiomyocyte resting tension in failing human myocardium. Circ Res (2009) 1.99
In utero meconium exposure increases spinal cord necrosis in a rat model of myelomeningocele. J Pediatr Surg (2002) 1.80
Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment. Heart Fail Rev (2012) 1.61
Meconium dependence of bowel damage in gastroschisis. J Pediatr Surg (2002) 1.50
Cardiovascular endothelins: essential regulators of cardiovascular homeostasis. Pharmacol Ther (2006) 1.42
Intraventricular pressure gradients throughout the cardiac cycle: effects of ischaemia and modulation by afterload. Exp Physiol (2012) 1.41
Apelin decreases myocardial injury and improves right ventricular function in monocrotaline-induced pulmonary hypertension. Am J Physiol Heart Circ Physiol (2009) 1.26
Diabetes mellitus worsens diastolic left ventricular dysfunction in aortic stenosis through altered myocardial structure and cardiomyocyte stiffness. Circulation (2011) 1.22
Ghrelin, des-acyl ghrelin and obestatin: three pieces of the same puzzle. Peptides (2008) 1.16
Myocardial titin hypophosphorylation importantly contributes to heart failure with preserved ejection fraction in a rat metabolic risk model. Circ Heart Fail (2013) 1.14
Effect of ivabradine on heart failure with preserved ejection fraction. J Am Coll Cardiol (2013) 1.08
Distinct mechanisms for diastolic dysfunction in diabetes mellitus and chronic pressure-overload. Basic Res Cardiol (2011) 1.05
Functional polymorphisms of Toll-like receptors 2 and 4 alter the risk for colorectal carcinoma in Europeans. Dig Liver Dis (2012) 1.01
Increased expression of toll-like receptors (TLR) 2, 4 and 5 in gastric dysplasia. Pathol Oncol Res (2011) 0.96
The apelinergic system: the role played in human physiology and pathology and potential therapeutic applications. Arq Bras Cardiol (2008) 0.96
Time course and mechanisms of left ventricular systolic and diastolic dysfunction in monocrotaline-induced pulmonary hypertension. Basic Res Cardiol (2009) 0.96
Apelin: a novel neurohumoral modulator of the cardiovascular system. Pathophysiologic importance and potential use as a therapeutic target. Rev Port Cardiol (2005) 0.95
Targeting myocardial remodelling to develop novel therapies for heart failure: a position paper from the Working Group on Myocardial Function of the European Society of Cardiology. Eur J Heart Fail (2014) 0.95
New pathways of the renin-angiotensin system: the role of ACE2 in cardiovascular pathophysiology and therapy. Expert Opin Ther Targets (2010) 0.94
Physiological, pathological and potential therapeutic roles of adipokines. Drug Discov Today (2012) 0.94
Attenuation of the cardiovascular and metabolic complications of obesity in CD14 knockout mice. Life Sci (2008) 0.94
Towards a re-definition of 'cardiac hypertrophy' through a rational characterization of left ventricular phenotypes: a position paper of the Working Group 'Myocardial Function' of the ESC. Eur J Heart Fail (2011) 0.92
Increased hepatic expression of TLR2 and TLR4 in the hepatic inflammation-fibrosis-carcinoma sequence. Innate Immun (2012) 0.92
Helicobacter pylori induces increased expression of Toll-like receptors and decreased Toll-interacting protein in gastric mucosa that persists throughout gastric carcinogenesis. Helicobacter (2012) 0.91
Cardiac venous arterialization in acute myocardial infarction: how great is the benefit? Interact Cardiovasc Thorac Surg (2012) 0.88
Acute changes of biventricular gene expression in volume and right ventricular pressure overload. Life Sci (2005) 0.88
Current pathophysiological concepts and management of pulmonary hypertension. Int J Cardiol (2012) 0.86
Pivotal role of microRNAs in cardiac physiology and heart failure. Drug Discov Today (2013) 0.85
M-mode and Doppler echocardiographic reference values for male New Zealand white rabbits. Am J Vet Res (2006) 0.84
Endogenous production of ghrelin and beneficial effects of its exogenous administration in monocrotaline-induced pulmonary hypertension. Am J Physiol Heart Circ Physiol (2004) 0.84
Cystic adenomatoid malformations are induced by localized FGF10 overexpression in fetal rat lung. Am J Respir Cell Mol Biol (2008) 0.84
Targeted gene transfer to fetal rat lung interstitium by ultrasound-guided intrapulmonary injection. Mol Ther (2007) 0.84
Hypertension and angiogenesis in the aging kidney: a review. Arch Gerontol Geriatr (2010) 0.84
Acute neurohumoral modulation of diastolic function. Peptides (2008) 0.83
Myocardial effects of endothelin-1. Rev Port Cardiol (2008) 0.83
Thymulin inhibits monocrotaline-induced pulmonary hypertension modulating interleukin-6 expression and suppressing p38 pathway. Endocrinology (2008) 0.83
The apelinergic system: a promising therapeutic target. Expert Opin Ther Targets (2010) 0.83
Myocardial dysfunction and neurohumoral activation without remodeling in left ventricle of monocrotaline-induced pulmonary hypertensive rats. Am J Physiol Heart Circ Physiol (2006) 0.83
Toll-like receptors as therapeutic targets in gastrointestinal diseases. Expert Opin Ther Targets (2010) 0.82
Echocardiographic evaluation including tissue Doppler imaging in New Zealand white rabbits sedated with ketamine and midazolam. Vet J (2008) 0.82
Decreased Toll-interacting protein and peroxisome proliferator-activated receptor γ are associated with increased expression of Toll-like receptors in colon carcinogenesis. J Clin Pathol (2012) 0.82
METformin in DIastolic Dysfunction of MEtabolic syndrome (MET-DIME) trial: rationale and study design : MET-DIME trial. Cardiovasc Drugs Ther (2014) 0.82
Intermedin elicits a negative inotropic effect in rat papillary muscles mediated by endothelial-derived nitric oxide. Am J Physiol Heart Circ Physiol (2012) 0.82
Therapeutic potential of neuregulin-1 in cardiovascular disease. Drug Discov Today (2013) 0.82
Adiponectin levels are elevated in patients with pulmonary arterial hypertension. Clin Cardiol (2013) 0.81
Effects of adrenomedullin on systolic and diastolic myocardial function. Peptides (2008) 0.81
Ghrelin expression in human and rat fetal lungs and the effect of ghrelin administration in nitrofen-induced congenital diaphragmatic hernia. Pediatr Res (2006) 0.81
Cardiovascular actions of adiponectin: pathophysiologic implications. Rev Port Cardiol (2008) 0.81
Concomitant unipolar radiofrequency ablation of nonparoxysmal atrial fibrillation in rheumatic and degenerative valve disease. J Card Surg (2014) 0.81
N-terminal-pro-B type natriuretic peptide as a useful tool to evaluate pulmonary hypertension and cardiac function in CDH infants. Neonatology (2007) 0.80
Inotropic and lusitropic effects of ghrelin and their modulation by the endocardial endothelium, NO, prostaglandins, GHS-R1a and KCa channels. Peptides (2006) 0.80
A Western-type diet attenuates pulmonary hypertension with heart failure and cardiac cachexia in rats. J Nutr (2011) 0.80
Antenatal vitamin A administration attenuates lung hypoplasia by interfering with early instead of late determinants of lung underdevelopment in congenital diaphragmatic hernia. J Pediatr Surg (2005) 0.79
Left intraventricular diastolic and systolic pressure gradients. Exp Biol Med (Maywood) (2011) 0.79
Impaired response to ET(B) receptor stimulation in heart failure: functional evidence of endocardial endothelial dysfunction? Exp Biol Med (Maywood) (2006) 0.79
Central nervous system circuits modified in heart failure: pathophysiology and therapeutic implications. Heart Fail Rev (2014) 0.79
Local modulation of the natriuretic peptide system in the rat remnant kidney. Nephrol Dial Transplant (2009) 0.79
Myocardial remote ischemic preconditioning: from pathophysiology to clinical application. Rev Port Cardiol (2013) 0.79
Angiotensin-(1-7) modulates angiotensin II-induced vasoconstriction in human mammary artery. Cardiovasc Drugs Ther (2014) 0.79
Fetal heart development in the nitrofen-induced CDH rat model: the role of mechanical and nonmechanical factors. J Pediatr Surg (2003) 0.78
Reverse myocardial effects of intermedin in pressure-overloaded hearts: role of endothelial nitric oxide synthase activity. J Physiol (2012) 0.78
Endothelin ETA receptors and endothelium partially mediate the positive inotropic and lusitropic effects of angiotensin II. Eur J Pharmacol (2006) 0.78
[Cardiorenal syndrome and its pathophysiological implications]. Rev Port Cardiol (2010) 0.78
Adipokines and their receptors: potential new targets in cardiovascular diseases. Future Med Chem (2015) 0.78
Cardiac dysfunction in HgCl2-induced nephrotic syndrome. Exp Biol Med (Maywood) (2010) 0.78
Angiotensin II-induced increase in myocardial distensibility and its modulation by the endocardial endothelium in the rabbit heart. Exp Physiol (2009) 0.77
Remote cardiac ischemic conditioning: underlying mechanisms and clinical applications. Rev Port Cir Cardiotorac Vasc (2014) 0.77
Urotensin II acutely increases myocardial length and distensibility: potential implications for diastolic function and ventricular remodeling. Naunyn Schmiedebergs Arch Pharmacol (2007) 0.77
Acute modulation of myocardial function by angiotensin 1-7. Peptides (2009) 0.77
A high-calorie diet attenuates cachexia and adipose tissue inflammation in monocrotaline-induced pulmonary hypertensive rats. Rev Port Cardiol (2010) 0.76
The effects of angiotensin II signaling pathway in the systolic response to acute stretch in the normal and ischemic myocardium. Peptides (2013) 0.76
Haemodynamic and neuroendocrine effects of tezosentan in chronic experimental pulmonary hypertension. Intensive Care Med (2012) 0.76
Role of Toll-like receptor impairment in cirrhosis infection risk: are we making progress? Liver Int (2010) 0.76
Modulation of the myocardial effects of selective ETB receptor stimulation and its implications for heart failure. Rev Port Cardiol (2005) 0.76
Pathophysiology of chronic heart failure. Rev Port Cardiol (2009) 0.76
[Calcium kinetics in the progression of heart failure]. Rev Port Cardiol (2004) 0.76
The role of titin in the modulation of cardiac function and its pathophysiological implications. Arq Bras Cardiol (2011) 0.76
Endothelin-converting enzyme inhibitors: their application in cardiovascular diseases. Rev Port Cardiol (2008) 0.76
Obligatory role of the endocardial endothelium in the increase of myocardial distensibility induced by endothelin-1. Exp Biol Med (Maywood) (2006) 0.76
Revisiting the slow force response: the role of the PKG signaling pathway in the normal and the ischemic heart. Rev Port Cardiol (2014) 0.76
Contractile effects of Ghrelin and expression of its receptor GHS-R1a in normal and hypertrophic myocardium. Rev Port Cardiol (2005) 0.76
Ghrelin reverses molecular, structural and hemodynamic alterations of the right ventricle in pulmonary hypertension. Rev Port Cardiol (2006) 0.75
Physiologic basis and pathophysiologic implications of the diastolic properties of the cardiac muscle. J Biomed Biotechnol (2010) 0.75
Remote myocardium gene expression after 30 and 120 min of ischaemia in the rat. Exp Physiol (2006) 0.75
Meeting highlights from the 2013 European Society of Cardiology Heart Failure Association Winter Meeting on Translational Heart Failure Research. Eur J Heart Fail (2013) 0.75
Effects of diabetes mellitus, pressure-overload and their association on myocardial structure and function. Am J Hypertens (2009) 0.75
Radiofrequency ablation of atrial fibrillation during concomitant cardiac surgery. Rev Port Cir Cardiotorac Vasc (2015) 0.75
[Nitric oxide in the physiopathology of myocardial dysfunction in heart failure]. Rev Port Cardiol (2004) 0.75
Ventricular BNP gene expression in acute cardiac overload. Rev Port Cardiol (2004) 0.75
Agreement between echocardiographic techniques in assessment of the left ventricular myocardial performance index in rabbits. Am J Vet Res (2009) 0.75
[Renin-angiotensin system and its role in cardiovascular physiopathology and therapy]. Rev Port Cardiol (2004) 0.75